Laura Jane Fish

Dr. Laura Jane Fish


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2013 in American Journal of Health Education
Verified
Journal Article
Closed access
LFLaura Jane Fish
Laura Jane Fish
PMPatricia G. Moorman
Patricia G. Moorman
LWLashawn Wordlaw-Stintson
Lashawn Wordlaw-Stintson
AVAdriana Vidal
Adriana Vidal
JSJennifer S. Smith
Jennifer S. Smith
CHCathrine Hoyo
Cathrine Hoyo
Background Understanding the gaps in knowledge about human papilloma virus (HPV) infection, transmission, and health consequences and factors associated with the knowledge gap is an essential first step for the development of interventions to improve adherence to follow-up among women with abnormal Pap smears. Purpose To examine the relationship between knowledge about HPV and adherence to scheduled colposcopic evaluation and variables related to lack of knowledge among women with abnormal Pap tests. Methods Telephone surveys were conducted with women who attended their scheduled appointments (adherers) and women who did not attend their appointments (nonadherers). Results The multivariable analyses indicate that lower HPV knowledge was independently associated with nonadherence to follow-up, controlling for race and education level. Factors related to lower knowledge scores included non-white race, lower education, and lack of health insurance at the time of the scheduled appointment. Conclusion Lack of knowledge of HPV was related to nonadherence among women scheduled for colposcopic evaluation. Translation to Health Education Practice Health education interventions that deliver complex information about HPV and cervical cancer should be in a format that is accessible and understandable to the women who are most at risk of being nonadherent.

10 February 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
SOSachiko M. Oshima
Sachiko M. Oshima
STSarah D. Tait
Sarah D. Tait
CRChristel Rushing
Christel Rushing
WLWhitney Lane
Whitney Lane
THTerry Hyslop
Terry Hyslop
LFLaura Jane Fish
Laura Jane Fish
PURPOSE: Although financial toxicity is a well-documented aspect of cancer care, little is known about how patients narratively characterize financial experiences related to breast cancer treatment. We sought to examine these patient experiences through mixed methods analysis.METHODS: Women (≥ 18 years old) with a history of breast cancer were recruited from the Love Research Army and Sisters Network to complete an 88-item electronic survey including an open-ended response. Quantitative data were used to sort and stratify responses to the open-ended question, which comprised the qualitative data evaluated here. Descriptive statistics and qualitative content analysis were used to evaluate the financial costs and other burdens resulting from breast cancer surgery.RESULTS: In total, 511 respondents completed the survey in its entirety and wrote an open-ended response. Participants reported significant financial burden in different categories including direct payments for medical care and indirect costs such as lost wages and travel expenses. Treatment-related costs burdened participants for years after diagnosis, forming a financial arc for many participants. Discrepancies existed between the degree of financial burden reported on multiple-choice questions and participants’ corresponding open-ended descriptions of financial burden. Participants described a lack of communication surrounding costs with their providers and difficulty negotiating payments with insurance.CONCLUSION: Breast cancer care can result in ongoing financial burden years after diagnosis among all patients, even those with adequate insurance patient populations.

17 March 2023 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Open access
AOAmy O’REgan
Amy O’REgan
LFLaura Jane Fish
Laura Jane Fish
CMChristina Makarushka
Christina Makarushka
TSTamara J. Somers
Tamara J. Somers
KJKatie Fitzgerald Jones
Katie Fitzgerald Jones
DCDevon Check
Devon Check
Objectives: Many cancer survivors experience chronic pain after completing curative-intent treatment. Based on available data, chronic pain may be undertreated in this context; however, little is known about cancer survivors’ experiences with clinical management of chronic pain. The purpose of this study was to better understand cancer survivors’ pain management experiences after curative-intent treatment. Methods: We conducted 13 semi-structured interviews with a convenience sample of cancer survivors who had completed treatment for stage I-III breast, head/neck, lung or colorectal cancer. We used a thematic approach to qualitative data analysis. Results: Participants described that chronic pain often goes unrecognized by their providers, potentially due to limitations in how pain is assessed clinically and the tendency of both cancer survivors and providers to minimize or invalidate the pain experience. To improve communication, participants suggested that providers ask more open-ended questions about their pain, help them to establish functional goals, and provide patients with options for pain management. Significance of Results: This study demonstrates the importance of provider-initiated communication around pain management for cancer survivors to make them feel more supported in their care. Communication and shared decision-making interventions may improve cancer survivor-provider communication around chronic pain management, addressing an important gap in survivorship care.

19 April 2022 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
LFLaura Jane Fish
Laura Jane Fish
SHSayward Harrison
Sayward Harrison
JMJodi-Ann McDonald
Jodi-Ann McDonald
VYValerie Yelverton
Valerie Yelverton
CWCharnetta Williams
Charnetta Williams
LVLavanya Vasudevan
Lavanya Vasudevan
The objective of this study was to identify factors at the individual, provider, and systems levels that serve as challenges or opportunities for increasing adolescent vaccination—including Human Papillomavirus (HPV) vaccination—in rural communities in the southern United States (US). As part of a broader study to increase HPV vaccine uptake in the southern US, we conducted in-depth interviews with vaccination stakeholders representing public health and education agencies in North Carolina (NC) and South Carolina (SC). Fourteen key stakeholders were recruited using purposive sampling to obtain insights into challenges and solutions to rural-urban disparities in HPV vaccination coverage. Stakeholders were also queried about their experiences and attitudes toward school-based vaccination promotion programs and campaigns. We used a rapid qualitative approach to analyze the data. Stakeholders identified factors at the individual, provider, and systems levels that serve as challenges to vaccination in rural communities. Similar to previous studies, stakeholders mentioned challenges with healthcare access and vaccine-related misconceptions that pose barriers to HPV vaccination for rural residents. Systems-level challenges identified included limited access to high-speed internet in rural areas that may impact providers’ ability to interface with state-level digital systems such as the vaccination registry. Stakeholders identified a number of opportunities to increase HPV vaccination coverage, including through school-based health promotion programs. Stakeholders strongly supported school-based programs and approaches to strengthen confidence and demand for HPV vaccination and to help address persistent social determinants and system level factors that pose challenges to HPV vaccination coverage in many rural areas.

23 March 2021 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JPJuliessa M Pavon
Juliessa M Pavon
LFLaura Jane Fish
Laura Jane Fish
CCCathleen S. Colón‐Emeric
Cathleen S. Colón‐Emeric
KHKatherine Hall
Katherine Hall
MMMiriam C. Morey
Miriam C. Morey
SHS. Nicole Hastings
S. Nicole Hastings

12 June 2020 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
KPKathryn I. Pollak
Kathryn I. Pollak
PLPauline Lyna
Pauline Lyna
XGXiaomei Gao
Xiaomei Gao
DNDevon Noonan
Devon Noonan
SHSantiago Bejarano Hernandez
Santiago Bejarano Hernandez
LFLaura Jane Fish
Laura Jane Fish
Introduction: Smoking during pregnancy poses serious risks to baby and mother. Few disseminable programs exist to help pregnant women quit or reduce their smoking. We hypothesized that an SMS text-delivered scheduled gradual reduction (SGR) program plus support texts would outperform SMS support messages alone. Methods: We recruited 314 pregnant women from 14 prenatal clinics. Half of the women received theory-based support messages throughout their pregnancy to promote cessation and prevent relapse. The other half received the support messages plus alert texts that gradually reduced their smoking more than 3–5 weeks. We conducted surveys at baseline, end of pregnancy, and 3 months postpartum. Our primary outcome was biochemically validated 7-day point prevalence abstinence at late pregnancy. Our secondary outcome was reduction in cigarettes per day. Results: Adherence to the SGR was adequate with 70% responding to alert texts to smoke within 60 minutes. Women in both arms quit smoking at the same rate (9%–12%). Women also significantly reduced their smoking from baseline to the end of pregnancy from nine cigarettes to four; we found no arm differences in reduction. Conclusions: Support text messages alone produced significant quit rates above naturally occurring quitting. SGR did not add significantly to helping women quit or reduce. Sending support messages can reach many women and is low-cost. More obstetric providers might consider having patients who smoke sign up for free texting programs to help them quit. Implications: A disseminable texting program helped some pregnant women quit smoking. Clinical Trial Registration number: NCT01995097.